For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...

Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...

The technology is a form of targeted radiotherapy that uses a boron-containing drug. AXA China Region Insurance Company (Bermuda) Limited and AXA International Reinsurance (Shanghai) Company Limited ...

Prior to the Uveitis (Sycamore) Study, there were few evidence-based therapies for children with moderate to severe uveitis, leading to many suffering serious visual complications and often blindness.

The gold-level award is the highest recognition awarded by the AHA to EMS departments and organizations for implementing ...

Outpatient CAR T therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers tracked the in situ CAR-T cells to assess their effectiveness and safety.

Pimple patches have helped make acne ‘acceptable’ and added the fun into functionality, but now the format is expanding to ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...